Video Experimental Relacionado
Updated: Jul 7, 2026
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
c-fos se requiere para la progresión maligna de los tumores de piel
E Saez1, S E Rutberg, E Mueller
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cell
|September 8, 1995
Resumen
El proto-oncogén c-FOS es esencial para el desarrollo de tumores malignos. Los ratones con deficiencia de C-FOS desarrollaron tumores benignos pero no pudieron progresar a malignidad, lo que indica su papel crítico en la progresión del cáncer.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Genética La genética.
Sus antecedentes:
- El proto-oncogén c-FOS es un objetivo nuclear clave en las vías de señalización celular que regulan el crecimiento celular, la diferenciación y la transformación.
- Comprender el papel de c-FOS en la carcinogénesis es crucial para el desarrollo de terapias dirigidas contra el cáncer.
Objetivo del estudio:
- Para investigar el papel del gen c-FOS en el proceso de múltiples pasos de la carcinogénesis de la piel.
- Para determinar si la deficiencia de c-FOS previene la conversión maligna de tumores benignos.
Principales métodos:
- Utilizó un modelo de carcinogénesis cutánea en múltiples etapas en ratones con deficiencia de c-FOS que llevaban un transgén v-H-ras.
- Comparación del desarrollo tumoral y la cinética de la progresión entre el knockout de c-FOS y los animales de tipo salvaje.
- Empleó experimentos de injerto de queratinocitos para evaluar los defectos celulares en la tumorigénesis.
Principales resultados:
- Los ratones con deficiencia de c-FOS desarrollaron tumores benignos con una cinética similar a los ratones de tipo salvaje.
- Los papilomas en ratones con deficiencia de c-FOS exhibieron hiperqueratinización y no progresaron a una neoplasia maligna.
- Los experimentos de injerto indicaron un defecto celular intrínseco en la tumorigénesis en células deficientes en c-FOS.
Conclusiones:
- El factor de transcripción c-FOS, un miembro de la familia AP-1, es necesario para la conversión maligna de tumores benignos de la piel.
- c-FOS juega un papel crítico en la progresión del cáncer, no la iniciación.
- La orientación de las vías c-FOS puede ofrecer estrategias terapéuticas para prevenir la malignidad tumoral.
Videos de Conceptos Relacionados
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...